Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potencyMylan with its partners Lupin and Biocon received MAA for Nepexto (biosimilar, etanercept) in EU and the US FDA's Approval for Semglee (biosimilar, insulin glargine) respectivelyOur team at PharmaShots has summarized 15 key events of the…
